Income Before Tax

Pre-Tax Income (Foreign)

Vertex Pharmaceuticals Pre-Tax Income (Foreign) remained flat by 0.0% to $455.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 12.6%, from $404.55M to $455.50M. Over 2 years (FY 2023 to FY 2025), Pre-Tax Income (Foreign) shows an upward trend with a 18.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementIncome Statement
SectionIncome Before Tax
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ4 2025

How to read this metric

Growth indicates successful international expansion and global demand, while a decline may suggest geopolitical risks or competitive pressures in foreign markets.

Detailed definition

The portion of income from continuing operations generated outside the company's home country before the deduction of in...

Peer comparison

Standard for multinational industrial companies with significant global supply chains and service footprints.

Metric ID: is_msft_income_before_tax_foreign

Historical Data

3 years
 FY'23FY'24FY'25
Value$1.29B$1.62B$1.82B
YoY Change—+25.4%+12.6%
Range$1.29B – $1.82B
CAGR+18.8%
Avg YoY Growth+19.0%
Median YoY Growth+19.0%
Current Streak2+ years growth

Frequently Asked Questions

What is Vertex Pharmaceuticals's pre-tax income (foreign)?
Vertex Pharmaceuticals (VRTX) reported pre-tax income (foreign) of $455.50M in Q4 2025.
How has Vertex Pharmaceuticals's pre-tax income (foreign) changed year-over-year?
Vertex Pharmaceuticals's pre-tax income (foreign) increased by 12.6% year-over-year, from $404.55M to $455.50M.
What is the long-term trend for Vertex Pharmaceuticals's pre-tax income (foreign)?
Over 2 years (2023 to 2025), Vertex Pharmaceuticals's pre-tax income (foreign) has grown at a 18.8% compound annual growth rate (CAGR), from $1.29B to $1.82B.
What does pre-tax income (foreign) mean?
Pre-tax profit generated from business operations outside the home country.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.